Amicogen Inc (092040) — Capital Reinvestment Ratio

Latest as of December 2025: 0.10x

Amicogen Inc (092040) has a Capital Reinvestment Ratio of 0.10x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩1.11 Billion) in capital expenditures (₩113.49 Million). See Amicogen Inc balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.10x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.11 Billion
KRW

Capital Expenditures

₩113.49 Million
KRW

Data as of

Dec 2025
Most recent filing

Amicogen Inc Capital Reinvestment Ratio (2014–2023)

This chart tracks Amicogen Inc's Capital Reinvestment Ratio across 9 annual periods. Check 092040 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Amicogen Inc (2014–2023)

Year-by-year Capital Reinvestment Ratio for Amicogen Inc from 2014 to 2023. For live market cap and broader valuation context, see market value of Amicogen Inc.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2023 7.24x ₩8.64 Billion ₩62.60 Billion ▲ +23.6%
2021 5.86x ₩8.07 Billion ₩47.31 Billion ▲ +275.0%
2020 1.56x ₩8.87 Billion ₩13.85 Billion ▼ -28.9%
2019 2.20x ₩8.76 Billion ₩19.26 Billion ▼ -42.6%
2018 3.83x ₩2.84 Billion ₩10.88 Billion ▲ +297.7%
2017 0.96x ₩11.88 Billion ₩11.45 Billion ▼ -35.9%
2016 1.50x ₩11.28 Billion ₩16.95 Billion ▲ +153.4%
2015 0.59x ₩12.34 Billion ₩7.32 Billion ▼ -42.9%
2014 1.04x ₩4.43 Billion ₩4.60 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow